Head-To-Head Survey: Verano (OTCMKTS:VRNOF) & Intelligent Bio Solutions (NASDAQ:INBS)

Intelligent Bio Solutions (NASDAQ:INBS) and Verano (OTCMKTS:VRNOF) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Intelligent Bio Solutions and Verano, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1	1	0	0	1.50
Verano	1	0	0	1	2.50

Valuation & Earnings

This table compares Intelligent Bio Solutions and Verano”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$4.22 million	1.49	-$12.43 million	($9.02)	-0.23
Verano	$878.59 million	0.52	-$341.86 million	($0.98)	-1.29

Intelligent Bio Solutions has higher earnings, but lower revenue than Verano. Verano is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 9.0% of Verano shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 9.1% of Verano shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Intelligent Bio Solutions and Verano’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%
Verano	-41.68%	-9.54%	-4.51%

Risk and Volatility

Intelligent Bio Solutions has a beta of 4.25, suggesting that its stock price is 325% more volatile than the S&P 500. Comparatively, Verano has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Summary

Verano beats Intelligent Bio Solutions on 8 of the 13 factors compared between the two stocks.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Verano

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.